Results
|
1341.
|
|
|
1342.
|
|
|
1343.
|
Living related liver transplantation in patients with ABO incompatibility. [electronic resource] by
- Takayama, J
- Ohkohchi, N
- Oikawa, K
- Asakura, T
- Kawagishi, N
- Kikuchi, H
- Koyamada, N
- Orii, T
- Sakurada, M
- Doi, H
- Fujimori, K
- Katoh, H
- Satake, M
- Satomi, S
Producer: 19981228
In:
Transplantation proceedings vol. 30
Availability: No items available.
|
|
1344.
|
A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees. [electronic resource] by
- Hsu, D H
- Shi, J D
- Homola, M
- Rowell, T J
- Moran, J
- Levitt, D
- Druilhet, B
- Chinn, J
- Bullock, C
- Klingbeil, C
Producer: 19990922
In:
Transplantation vol. 68
Availability: No items available.
|
|
1345.
|
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. [electronic resource] by
- Herold, Kevan C
- Gitelman, Stephen
- Greenbaum, Carla
- Puck, Jennifer
- Hagopian, William
- Gottlieb, Peter
- Sayre, Peter
- Bianchine, Peter
- Wong, Emelita
- Seyfert-Margolis, Vicki
- Bourcier, Kasia
- Bluestone, Jeffrey A
Producer: 20090917
In:
Clinical immunology (Orlando, Fla.) vol. 132
Availability: No items available.
|
|
1346.
|
|
|
1347.
|
|
|
1348.
|
|
|
1349.
|
|
|
1350.
|
|
|
1351.
|
|
|
1352.
|
|
|
1353.
|
|
|
1354.
|
|
|
1355.
|
Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection. [electronic resource] by
- Midtvedt, K
- Tafjord, A B
- Hartmann, A
- Eide, T C
- Holdaas, H
- Nordal, K P
- Draganov, B
- Sødal, G
- Leivestad, T
- Fauchald, P
Producer: 19960828
In:
Transplantation vol. 62
Availability: No items available.
|
|
1356.
|
|
|
1357.
|
|
|
1358.
|
|
|
1359.
|
|
|
1360.
|
|